CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, July 29th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...